| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $80.2M | — | +55.2% |
| Cost of Revenue | $53.7M | — | +41.7% |
| Gross Profit | $26.5M | — | +92.1% |
| R&D Expense | $11.8M | — | +4.1% |
| SG&A Expense | $15.1M | — | +25.4% |
| Operating Income | -$719K | — | +92.5% |
| Pre-tax Income | $698K | — | +108.8% |
| Income Tax | $53K | — | -61.3% |
| Net Income | $645K | — | +108.0% |
| EPS (Basic) | $0.01 | — | +106.3% |
| EPS (Diluted) | $0.01 | — | +106.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $298.2M | +202.1% | +262.8% |
| Accounts Receivable | $48.1M | -5.4% | +31.5% |
| Inventory | $43.9M | -3.4% | +0.2% |
| Current Assets | $446.1M | +83.4% | +106.7% |
| Total Assets | $515.7M | +63.6% | +77.8% |
| Current Liabilities | $63.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $9.7M | — | — |
| Capital Expenditures | $2.1M | — | -7.4% |
| Investing Cash Flow | -$1.4M | — | +43.8% |
| Financing Cash Flow | $191.2M | — | +919.1% |
| Free Cash Flow | $7.6M | — | +429.0% |
| +69.7% |
| Total Liabilities | $86.5M | -2.3% | +11.9% |
| Stockholders' Equity | $429.2M | +89.3% | +101.7% |